Olestra and the FDA.
Manning
W J
WJ
D000075202:Contraindications; D004042:Dietary Fats, Unsaturated / Q000494:pharmacology; D005227:Fatty Acids / Q000494:pharmacology; D006801:Humans; D013395:Sucrose / Q000031:analogs & derivatives* / Q000494:pharmacology; D014481:United States; D014486:United States Food and Drug Administration; D014812:Vitamin K / Q000037:antagonists & inhibitors / Q000378:metabolism; D014859:Warfarin / Q000494:pharmacology
D004042:Dietary Fats, Unsaturated; D005227:Fatty Acids; D014812:Vitamin K; D013395:Sucrose; D014859:Warfarin; C013692:sucrose polyester